Bitcoin's price fell below the $81,000 mark to $80,930 on Binance's spot market as of 5:57 p.m. ET on October 27. This drop occurred within a 15-minute window, moving from $81,061 to $80,930, a decrease of $131. Despite this short-term dip, Bitcoin's price showed a slight positive change of 0.19% over the past hour. The movement highlights Bitcoin's price volatility around key psychological levels, which investors closely watch for market trends.
Bitcoin's recent price drop below $81,000 provides context for cryptocurrency market activity on Pluang. For readers following digital assets, here is Pluang's market snapshot as of Oct 28, 2026 05:03 WIB: out of 50 major cryptocurrencies, 34 rose and 14 fell today. XRP (Ripple) was priced at Rp23.930 with a 1-day change of +2.55%, ZIL (Zilliqa) at Rp36 with +2.28%, and FTM (Fantom) at Rp11.382 with a 1-day change of -2.05%.
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
Eli Lilly has outpaced Novo Nordisk in the GLP-1, obesity, and Type 2 Diabetes market, achieving a $1.21 trillion valuation. While Novo Nordisk's share price has fallen back after earlier gains and revenue growth remains flat, its management's strate...
argenx SE announced it will stop its Phase 3 UNITY study of efgartigimod subcutaneous for moderate-to-severe Sjögren's disease after an independent committee found the trial unlikely to meet its primary goal. This decision caused the company's stock ...
Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a sharp stock price drop triggered by a new U.S. federal strategy targeting the dialysis market. The Department of Health and Human Services announced a plan to incre...
Pomerantz LLP is investigating ClearPoint Neuro and its executives for possible securities fraud following a significant stock price drop. The decline occurred after ClearPoint's partner, uniQure, announced that their Huntington's disease treatment f...
